AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • May 2nd, 2023 • TradeUP Acquisition Corp. • Biological products, (no disgnostic substances)
This Amendment No. 1 To License Agreement (this “Amendment”), effective as of October 1, 2022 (the “First Amendment Date”), is entered into by and between Eureka Therapeutics, Inc., a Delaware corporation (“Eureka”) and Estrella Biopharma, Inc., a Delaware corporation (“Estrella”). Eureka and Estrella are referred to in this Amendment individually as a “Party” and collectively as the “Parties”.
